Shanghai Sanyou Medical Co., Ltd (SHA:688085)
17.28
-0.27 (-1.54%)
Apr 28, 2025, 2:45 PM CST
Shanghai Sanyou Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | - | 95.58 | 190.82 | 186.37 | 118.56 | Upgrade
|
Depreciation & Amortization | - | 28.63 | 18.99 | 15.49 | 10.04 | Upgrade
|
Other Amortization | - | 25.75 | 15.23 | 12.65 | 9.33 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 0.05 | 0.06 | -0.04 | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | 2.83 | 0.78 | Upgrade
|
Loss (Gain) From Sale of Investments | - | 6.89 | -41.59 | -53.77 | -20.43 | Upgrade
|
Provision & Write-off of Bad Debts | - | -8.76 | 2.79 | - | - | Upgrade
|
Other Operating Activities | - | 29.58 | 20.56 | 9.11 | 0.33 | Upgrade
|
Change in Accounts Receivable | - | 214.68 | -39.32 | -70.1 | -32.14 | Upgrade
|
Change in Inventory | - | -73.57 | -55.03 | -40.6 | -40.4 | Upgrade
|
Change in Accounts Payable | - | -65.73 | 39.84 | 75.88 | 25.32 | Upgrade
|
Change in Other Net Operating Assets | - | -0.23 | 0.77 | 4.04 | 2.91 | Upgrade
|
Operating Cash Flow | - | 267.43 | 155.97 | 144.92 | 77.52 | Upgrade
|
Operating Cash Flow Growth | - | 71.46% | 7.63% | 86.94% | 25.60% | Upgrade
|
Capital Expenditures | - | -25.94 | -138.2 | -91.66 | -30.45 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.15 | - | 0.37 | 0 | Upgrade
|
Cash Acquisitions | - | -30.38 | -0.97 | -268.48 | - | Upgrade
|
Investment in Securities | - | 123.88 | -25.86 | 356 | -820.36 | Upgrade
|
Other Investing Activities | - | 1.08 | 8.88 | 16.14 | 20.42 | Upgrade
|
Investing Cash Flow | - | 68.8 | -156.15 | 12.36 | -830.39 | Upgrade
|
Long-Term Debt Repaid | - | -3.55 | -4.52 | -1.46 | - | Upgrade
|
Net Debt Issued (Repaid) | - | -3.55 | -4.52 | -1.46 | - | Upgrade
|
Issuance of Common Stock | - | - | - | - | 995.25 | Upgrade
|
Common Dividends Paid | - | -19.2 | -37.37 | -35.86 | - | Upgrade
|
Other Financing Activities | - | - | - | - | -17.06 | Upgrade
|
Financing Cash Flow | - | -22.75 | -41.9 | -37.32 | 978.2 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 0.44 | 0.19 | -0.1 | -0.33 | Upgrade
|
Net Cash Flow | - | 313.92 | -41.88 | 119.85 | 225 | Upgrade
|
Free Cash Flow | - | 241.5 | 17.78 | 53.26 | 47.07 | Upgrade
|
Free Cash Flow Growth | - | 1258.46% | -66.62% | 13.15% | - | Upgrade
|
Free Cash Flow Margin | - | 52.45% | 2.74% | 8.98% | 12.06% | Upgrade
|
Free Cash Flow Per Share | - | 0.96 | 0.07 | 0.22 | 0.21 | Upgrade
|
Cash Income Tax Paid | - | 71.76 | 119.5 | 69.84 | 45.84 | Upgrade
|
Levered Free Cash Flow | - | 228.66 | -54.62 | 41.23 | 78.6 | Upgrade
|
Unlevered Free Cash Flow | - | 228.83 | -54.49 | 41.33 | 78.6 | Upgrade
|
Change in Net Working Capital | - | -136.9 | 59.58 | -14.81 | -24.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.